Establishing CUX1 as a determinant of Hematopoietic Stem cell heterogeneity
Establishing CUX1 as a determinant of Hematopoietic Stem cell heterogeneity
批准号:
10707891
负责人:
Tanner Clark Martinez
金额:
$5.27万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-30 至 2027-09-29
关键词:
AddressBindingBioinformaticsBiologicalBiologyBlood PlateletsC-terminalCatastrophic IllnessCationsCell CompartmentationCell CycleCell LineCell surfaceCellsChildhoodChromatinChromatin Remodeling FactorChromosomesClinicalCommunicationCuesCytoplasmDataDepositionDevelopmentDevelopmental BiologyDiagnosisDiseaseDoseDysplasiaEnhancersEquilibriumErythropoiesisEtiologyExhibitsFluorescenceGene ExpressionGenerationsGenesGenetic TranscriptionGenomicsGoalsHematologic NeoplasmsHematopoiesisHematopoieticHematopoietic NeoplasmsHematopoietic Stem Cell heterogeneityHematopoietic stem cellsHeterogeneityHomologous GeneHumanImmunophenotypingK562 CellsLinkLongevityLymphoidLymphopoiesisMapsMentorsMethodsModelingMolecularMultipotent Stem CellsMusMutationMyelogenousMyelopoiesisMyeloproliferative diseaseOrganismOutcomePatientsPerformancePhenotypePhysiciansPlayPopulationPropertyProteinsRecording of previous eventsRecurrenceRegulationReporterReportingReproducibilityRoleScientistSortingSystemTissuesTrainingTransplantationTumor Suppressor ProteinsUndifferentiatedVariantbody systemcell behaviordosageepigenomicsextracellulargene repressionhigh riskhomeodomainimproved outcomeinsightknock-downknowledgebasemolecular scalemouse modelnovel therapeuticsprospectiverecruitself-renewalskillsstem cell biologystem cellstranscription factortranscriptome
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
Hematopoietic stem cells (HSCs) exhibit heterogeneity with respect to repopulating capacity, lineage bias,
and cell cycle participation. Teleologically, heterogeneity is the result of stem cells making fundamental
decisions regarding the population of the tissue. Differences in stem cell behavior have been linked to the
expression of cell surface and cytoplasmic markers without mechanistic explanation. HSC heterogeneity has
not previously been attributed to a transcription factor. We propose the observed heterogeneity in HSCs can
be explained by the actions of a dose-dependent, homeodomain-containing transcription factor, CUX1. Three
lines of evidence suggest CUX1 to be a putative orchestrator of HSC heterogeneity: it recurrently acts in a
dose-dependent manner across developmental systems, its recurrent loss in high-risk hematopoietic disease,
and its role in chromatin regulation.
I report the generation of a CUX1mCherry reporter mouse to study the role of CUX1 in hematopoiesis. The
Cux1mCherry mouse is the result of an in-frame, C-terminal mCherry tag at the endogenous CUX1 locus. The
addition of the tag creates no aberrant hematopoietic phenotype, suggesting this is a suitable model for the
proposed studies. The immunophenotypic long-term HSC (LT-HSC) compartment has among the greatest
variances in CUX1 expression. Across CUX1 protein levels in the LT-HSC compartment, we report several
correlations to strongly suggest that the observed variation in CUX1 protein results in meaningful differences in
stem cell behavior. For example, CUX1Bright HSCs are more likely to be cycling than CUX1Int and CUX1Dim
HSCs at steady state. Thus, our studies suggest that CUX1 is playing a dose-dependent role in murine
hematopoietic stem and progenitor cells (HSPCs). This proposal aims to (i) establish the role of CUX1 in
lineage bias and repopulating capacity and (ii) determine the mechanism by which CUX1 exerts a dose-
dependent role. Accomplishing the proposed studies will illuminate an important paradigm in developmental
biology: how a small pool of stem cells balance self-renewal and differentiation to give rise to all the mature
cells in a tissue. An etiological understanding of stem cell behavior will provide new insights into the
development of new therapies for the many diseases that arise in HSCs.
The project I propose here is accompanied by a training plan developed by me and my mentors that
delineates four goals I will need to accomplish to propel me towards becoming a successful independent
physician-scientist. These four goals include gaining expertise in hematopoiesis, gaining expertise in
bioinformatics, developing proficiency in scientific communication, and integrating the scientific and clinical
aspects of my training. Realizing these goals will give me the skills that I need to be a physician-scientist well-
equipped to address meaningful biological questions related to the catastrophic illnesses of childhood.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: